What an awesome bunch of people. Feeling all the feels catching up with the IPOS FORwards research family Seriously such a clever, collaborative and just generally great crew

Despite its a small country meeting in Netherlands 🇱🇺didn't work out💁🏼‍♀️. In Toronto 🇨🇦 at #IPOS2022 finally got time to grab a coffee with my incredibly talented Dutch early career peers to talk about our ambitions and plans for the future Vivian Burgers @ Naomi vd Velden.

Kicking of the last #ipos2022 day with a mixed method study of Lauren Rudy. Survivors in rural areas report higher #FCR, have less access to medical and mental health resources and experience greater mental health stigma. Tele-health interventions might help.

So excited that A/Prof Nicole Rankin is a speaker at #ipos2022 and stresses the importance of #implementation. Let's work together to translate our research in to practice!

At 15:00 I will present our findings on the barriers and facilitators for #implementation of an evidence based #FCR intervention. For those of you that have energy ⚡left after so many great talks, very welcome to join and learn about our findings. #ipos2022 José Custers

Very last presentation in the last session of #ipos2022 stresses such an important topic. Financial stress is common in cancer patients who often face unexpected and high treatment costs. Dr Carolyn Mazariego-Jones discusses pathways to implement Informed Fiancial Consent.

#IPOS2024 kicks off with first session on #fearofrecurrence. 7% of ppl with #headandneck cancer consistently report high FCR. A/Prof Ben Smith @bensmithphd.bsky.social presenting clinical pathway for #fearofrecurrence screening.

An honour to present a clinical pathway for #Cancer #FearofRecurrence at #IPOS2024 on behalf of an awesome team. For anyone who's interested you'll be able to read more in Journal of Cancer Survivorship soon! Thanks to Cancer Institute NSW for their support & to all those who contributed to this work #PsyOnc

Happy to be part of a very diverse #ehealth session at #IPOS2024 and share our lessons learned about eHealth advantages and barriers. There is still a long way to go regarding implementation.

Honoured to present the work of our research group on trajectories of #FCR in HNC patients. 7% of patients have high stable FCR up to 3 years post treatment, a larger group is resilient. #IPOS2024 José Custers Linda Kwakkenbos

Great implementation session where 4 research groups share their successes and lessons learned with #implementation of innovations into clinical practice. First up implementing PROMs in pediatric oncology care #IPOS2024.

The uptake of cancer related #fatigue interventions is dependent on patients perceived care need and care seeking. Having a symptom is not necessarily related to having a care need #IPOS2024

Despite involving stakeholders from scratch and putting much effort into #implementation, researchers found that maintaining psychosocial interventions on the long term is challenging. Sharing our 'brilliant failures' is valuable #IPOS2024

The SWORD and BREATH implementation roadmaps show that study sample is not always representative for the clinical population. Barriers related to IP, finances and eHealth need to be adressed #IPOS2024

Some pragmatic recommendations for progressing #psyonc care in India from Prof Jayita Deodhar. A lack of specialist psycho-oncologists highlights the need for training other disciplines to provide multidisciplinary care #IPOS2024

Very proud of my colleague and mentor José Custers who received a #IPOS New Investigator award for her research on #FCR from conceptualization to implementation.

Great session about adaptation of the FORT FCR intervention to another culture, caregivers and AYA's. The speakers show the importance of a systematic adaptation approach balancing tailoring with fidelity to core elements.